OVID
Ovid Therapeutics Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$1.48
$-0.07
(-4.52%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $105.39M | EPS (ttm) | $-0.50 | Current Price | $1.48 |
| Enterprise Value | $98.54M | Forward EPS | $-0.37 | Previous Close | $1.55 |
| P/E Ratio | - | ROA | -29.33% | 52W High | $2.01 |
| Forward P/E | -3.99 | ROE | -60.06% | 52W Low | $0.24 |
| PEG Ratio | - | Gross Margin | 100.00% | 50 Day Avg | $1.62 |
| P/S Ratio | 15.94 | Operating Margin | -9487.12% | 200 Day Avg | $1.03 |
| P/B Ratio | 2.36 | Profit Margin | - | Volume | 2.53M |
| EV/EBITDA | -2.55 | Current Ratio | 4.24 | Avg Volume | 1.63M |
| EV/Sales | 14.91 | Quick Ratio | 3.77 | Beta | 0.26 |
| Employees | 23.00 | Debt/Equity | 30.79 | Shares Outstanding | 71.21M |
| Sector | Healthcare | Total Debt | $13.76M | Float Shares | 54.45M |
| Industry | Biotechnology | Total Cash | $25.60M | Short Float | 8.08% |
| Optionable | Yes | Cash/Share | $0.36 | Short Ratio | 3.17 |
| Dividend Yield | - | Book Value/Share | $0.63 | % Held by Insiders | 9.82% |
| Target Price | $4.05 | Revenue (TTM) | $6.61M | % Held by Institutions | 33.70% |